Pharma & Healthcare

Primary Antibody - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

The global market for Primary Antibody was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Primary Antibody was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Primary Antibody was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Primary Antibody was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Primary Antibody include Bio-Rad, Biorbyt, Abcam, Thermo Fisher Scientific, Creative Diagnostics, Novus Biologicals, SouthernBiotech, Boster Bio and OriGene, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Primary Antibody, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Primary Antibody by region & country, by Type, and by Application.
The Primary Antibody market size, estimations, and forecasts are provided in terms of sales volume (mg) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Primary Antibody.
Market Segmentation
By Company
Bio-Rad
Biorbyt
Abcam
Thermo Fisher Scientific
Creative Diagnostics
Novus Biologicals
SouthernBiotech
Boster Bio
OriGene
Genscript Biotech
Proteintech
Roche Diagnostics
HyTest
Segment by Type:
Monoclonal Antibodies
Polyclonal Antibody
Segment by Application
Hospital
Life Sciences
Laboratory
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Primary Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Primary Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Primary Antibody in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Primary Antibody Product Introduction
1.2 Global Primary Antibody Market Size Forecast
1.2.1 Global Primary Antibody Sales Value (2019-2030)
1.2.2 Global Primary Antibody Sales Volume (2019-2030)
1.2.3 Global Primary Antibody Sales Price (2019-2030)
1.3 Primary Antibody Market Trends & Drivers
1.3.1 Primary Antibody Industry Trends
1.3.2 Primary Antibody Market Drivers & Opportunity
1.3.3 Primary Antibody Market Challenges
1.3.4 Primary Antibody Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Primary Antibody Players Revenue Ranking (2023)
2.2 Global Primary Antibody Revenue by Company (2019-2024)
2.3 Global Primary Antibody Players Sales Volume Ranking (2023)
2.4 Global Primary Antibody Sales Volume by Company Players (2019-2024)
2.5 Global Primary Antibody Average Price by Company (2019-2024)
2.6 Key Manufacturers Primary Antibody Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Primary Antibody Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Primary Antibody
2.9 Primary Antibody Market Competitive Analysis
2.9.1 Primary Antibody Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Primary Antibody Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Antibody as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Monoclonal Antibodies
3.1.2 Polyclonal Antibody
3.2 Global Primary Antibody Sales Value by Type
3.2.1 Global Primary Antibody Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Primary Antibody Sales Value, by Type (2019-2030)
3.2.3 Global Primary Antibody Sales Value, by Type (%) (2019-2030)
3.3 Global Primary Antibody Sales Volume by Type
3.3.1 Global Primary Antibody Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Primary Antibody Sales Volume, by Type (2019-2030)
3.3.3 Global Primary Antibody Sales Volume, by Type (%) (2019-2030)
3.4 Global Primary Antibody Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Life Sciences
4.1.3 Laboratory
4.2 Global Primary Antibody Sales Value by Application
4.2.1 Global Primary Antibody Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Primary Antibody Sales Value, by Application (2019-2030)
4.2.3 Global Primary Antibody Sales Value, by Application (%) (2019-2030)
4.3 Global Primary Antibody Sales Volume by Application
4.3.1 Global Primary Antibody Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Primary Antibody Sales Volume, by Application (2019-2030)
4.3.3 Global Primary Antibody Sales Volume, by Application (%) (2019-2030)
4.4 Global Primary Antibody Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Primary Antibody Sales Value by Region
5.1.1 Global Primary Antibody Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Primary Antibody Sales Value by Region (2019-2024)
5.1.3 Global Primary Antibody Sales Value by Region (2025-2030)
5.1.4 Global Primary Antibody Sales Value by Region (%), (2019-2030)
5.2 Global Primary Antibody Sales Volume by Region
5.2.1 Global Primary Antibody Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Primary Antibody Sales Volume by Region (2019-2024)
5.2.3 Global Primary Antibody Sales Volume by Region (2025-2030)
5.2.4 Global Primary Antibody Sales Volume by Region (%), (2019-2030)
5.3 Global Primary Antibody Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Primary Antibody Sales Value, 2019-2030
5.4.2 North America Primary Antibody Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Primary Antibody Sales Value, 2019-2030
5.5.2 Europe Primary Antibody Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Primary Antibody Sales Value, 2019-2030
5.6.2 Asia Pacific Primary Antibody Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Primary Antibody Sales Value, 2019-2030
5.7.2 South America Primary Antibody Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Primary Antibody Sales Value, 2019-2030
5.8.2 Middle East & Africa Primary Antibody Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Primary Antibody Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Primary Antibody Sales Value
6.2.1 Key Countries/Regions Primary Antibody Sales Value, 2019-2030
6.2.2 Key Countries/Regions Primary Antibody Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Primary Antibody Sales Value, 2019-2030
6.3.2 United States Primary Antibody Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Primary Antibody Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Primary Antibody Sales Value, 2019-2030
6.4.2 Europe Primary Antibody Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Primary Antibody Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Primary Antibody Sales Value, 2019-2030
6.5.2 China Primary Antibody Sales Value by Type (%), 2023 VS 2030
6.5.3 China Primary Antibody Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Primary Antibody Sales Value, 2019-2030
6.6.2 Japan Primary Antibody Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Primary Antibody Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Primary Antibody Sales Value, 2019-2030
6.7.2 South Korea Primary Antibody Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Primary Antibody Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Primary Antibody Sales Value, 2019-2030
6.8.2 Southeast Asia Primary Antibody Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Primary Antibody Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Primary Antibody Sales Value, 2019-2030
6.9.2 India Primary Antibody Sales Value by Type (%), 2023 VS 2030
6.9.3 India Primary Antibody Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bio-Rad
7.1.1 Bio-Rad Company Information
7.1.2 Bio-Rad Introduction and Business Overview
7.1.3 Bio-Rad Primary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Bio-Rad Primary Antibody Product Offerings
7.1.5 Bio-Rad Recent Development
7.2 Biorbyt
7.2.1 Biorbyt Company Information
7.2.2 Biorbyt Introduction and Business Overview
7.2.3 Biorbyt Primary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Biorbyt Primary Antibody Product Offerings
7.2.5 Biorbyt Recent Development
7.3 Abcam
7.3.1 Abcam Company Information
7.3.2 Abcam Introduction and Business Overview
7.3.3 Abcam Primary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Abcam Primary Antibody Product Offerings
7.3.5 Abcam Recent Development
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Company Information
7.4.2 Thermo Fisher Scientific Introduction and Business Overview
7.4.3 Thermo Fisher Scientific Primary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Thermo Fisher Scientific Primary Antibody Product Offerings
7.4.5 Thermo Fisher Scientific Recent Development
7.5 Creative Diagnostics
7.5.1 Creative Diagnostics Company Information
7.5.2 Creative Diagnostics Introduction and Business Overview
7.5.3 Creative Diagnostics Primary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Creative Diagnostics Primary Antibody Product Offerings
7.5.5 Creative Diagnostics Recent Development
7.6 Novus Biologicals
7.6.1 Novus Biologicals Company Information
7.6.2 Novus Biologicals Introduction and Business Overview
7.6.3 Novus Biologicals Primary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Novus Biologicals Primary Antibody Product Offerings
7.6.5 Novus Biologicals Recent Development
7.7 SouthernBiotech
7.7.1 SouthernBiotech Company Information
7.7.2 SouthernBiotech Introduction and Business Overview
7.7.3 SouthernBiotech Primary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.7.4 SouthernBiotech Primary Antibody Product Offerings
7.7.5 SouthernBiotech Recent Development
7.8 Boster Bio
7.8.1 Boster Bio Company Information
7.8.2 Boster Bio Introduction and Business Overview
7.8.3 Boster Bio Primary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Boster Bio Primary Antibody Product Offerings
7.8.5 Boster Bio Recent Development
7.9 OriGene
7.9.1 OriGene Company Information
7.9.2 OriGene Introduction and Business Overview
7.9.3 OriGene Primary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.9.4 OriGene Primary Antibody Product Offerings
7.9.5 OriGene Recent Development
7.10 Genscript Biotech
7.10.1 Genscript Biotech Company Information
7.10.2 Genscript Biotech Introduction and Business Overview
7.10.3 Genscript Biotech Primary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Genscript Biotech Primary Antibody Product Offerings
7.10.5 Genscript Biotech Recent Development
7.11 Proteintech
7.11.1 Proteintech Company Information
7.11.2 Proteintech Introduction and Business Overview
7.11.3 Proteintech Primary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Proteintech Primary Antibody Product Offerings
7.11.5 Proteintech Recent Development
7.12 Roche Diagnostics
7.12.1 Roche Diagnostics Company Information
7.12.2 Roche Diagnostics Introduction and Business Overview
7.12.3 Roche Diagnostics Primary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Roche Diagnostics Primary Antibody Product Offerings
7.12.5 Roche Diagnostics Recent Development
7.13 HyTest
7.13.1 HyTest Company Information
7.13.2 HyTest Introduction and Business Overview
7.13.3 HyTest Primary Antibody Sales, Revenue and Gross Margin (2019-2024)
7.13.4 HyTest Primary Antibody Product Offerings
7.13.5 HyTest Recent Development
8 Industry Chain Analysis
8.1 Primary Antibody Industrial Chain
8.2 Primary Antibody Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Primary Antibody Sales Model
8.5.2 Sales Channel
8.5.3 Primary Antibody Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Primary Antibody Market Trends
Table 2. Primary Antibody Market Drivers & Opportunity
Table 3. Primary Antibody Market Challenges
Table 4. Primary Antibody Market Restraints
Table 5. Global Primary Antibody Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Primary Antibody Revenue Market Share by Company (2019-2024)
Table 7. Global Primary Antibody Sales Volume by Company (2019-2024) & (mg)
Table 8. Global Primary Antibody Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Primary Antibody Price by Company (2019-2024) & (USD/mg)
Table 10. Key Manufacturers Primary Antibody Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Primary Antibody Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Primary Antibody
Table 13. Global Primary Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Antibody as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Primary Antibody Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Primary Antibody Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Primary Antibody Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Primary Antibody Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Primary Antibody Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Primary Antibody Sales Volume by Type: 2019 VS 2023 VS 2030 (mg)
Table 22. Global Primary Antibody Sales Volume by Type (2019-2024) & (mg)
Table 23. Global Primary Antibody Sales Volume by Type (2025-2030) & (mg)
Table 24. Global Primary Antibody Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Primary Antibody Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Primary Antibody Price by Type (2019-2024) & (USD/mg)
Table 27. Global Primary Antibody Price by Type (2025-2030) & (USD/mg)
Table 28. Global Primary Antibody Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Primary Antibody Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Primary Antibody Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Primary Antibody Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Primary Antibody Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Primary Antibody Sales Volume by Application: 2019 VS 2023 VS 2030 (mg)
Table 34. Global Primary Antibody Sales Volume by Application (2019-2024) & (mg)
Table 35. Global Primary Antibody Sales Volume by Application (2025-2030) & (mg)
Table 36. Global Primary Antibody Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Primary Antibody Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Primary Antibody Price by Application (2019-2024) & (USD/mg)
Table 39. Global Primary Antibody Price by Application (2025-2030) & (USD/mg)
Table 40. Global Primary Antibody Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Primary Antibody Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Primary Antibody Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Primary Antibody Sales Value by Region (2019-2024) & (%)
Table 44. Global Primary Antibody Sales Value by Region (2025-2030) & (%)
Table 45. Global Primary Antibody Sales Volume by Region (mg): 2019 VS 2023 VS 2030
Table 46. Global Primary Antibody Sales Volume by Region (2019-2024) & (mg)
Table 47. Global Primary Antibody Sales Volume by Region (2025-2030) & (mg)
Table 48. Global Primary Antibody Sales Volume by Region (2019-2024) & (%)
Table 49. Global Primary Antibody Sales Volume by Region (2025-2030) & (%)
Table 50. Global Primary Antibody Average Price by Region (2019-2024) & (USD/mg)
Table 51. Global Primary Antibody Average Price by Region (2025-2030) & (USD/mg)
Table 52. Key Countries/Regions Primary Antibody Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Primary Antibody Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Primary Antibody Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Primary Antibody Sales Volume, (2019-2024) & (mg)
Table 56. Key Countries/Regions Primary Antibody Sales Volume, (2025-2030) & (mg)
Table 57. Bio-Rad Company Information
Table 58. Bio-Rad Introduction and Business Overview
Table 59. Bio-Rad Primary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 60. Bio-Rad Primary Antibody Product Offerings
Table 61. Bio-Rad Recent Development
Table 62. Biorbyt Company Information
Table 63. Biorbyt Introduction and Business Overview
Table 64. Biorbyt Primary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 65. Biorbyt Primary Antibody Product Offerings
Table 66. Biorbyt Recent Development
Table 67. Abcam Company Information
Table 68. Abcam Introduction and Business Overview
Table 69. Abcam Primary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 70. Abcam Primary Antibody Product Offerings
Table 71. Abcam Recent Development
Table 72. Thermo Fisher Scientific Company Information
Table 73. Thermo Fisher Scientific Introduction and Business Overview
Table 74. Thermo Fisher Scientific Primary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 75. Thermo Fisher Scientific Primary Antibody Product Offerings
Table 76. Thermo Fisher Scientific Recent Development
Table 77. Creative Diagnostics Company Information
Table 78. Creative Diagnostics Introduction and Business Overview
Table 79. Creative Diagnostics Primary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 80. Creative Diagnostics Primary Antibody Product Offerings
Table 81. Creative Diagnostics Recent Development
Table 82. Novus Biologicals Company Information
Table 83. Novus Biologicals Introduction and Business Overview
Table 84. Novus Biologicals Primary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 85. Novus Biologicals Primary Antibody Product Offerings
Table 86. Novus Biologicals Recent Development
Table 87. SouthernBiotech Company Information
Table 88. SouthernBiotech Introduction and Business Overview
Table 89. SouthernBiotech Primary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 90. SouthernBiotech Primary Antibody Product Offerings
Table 91. SouthernBiotech Recent Development
Table 92. Boster Bio Company Information
Table 93. Boster Bio Introduction and Business Overview
Table 94. Boster Bio Primary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 95. Boster Bio Primary Antibody Product Offerings
Table 96. Boster Bio Recent Development
Table 97. OriGene Company Information
Table 98. OriGene Introduction and Business Overview
Table 99. OriGene Primary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 100. OriGene Primary Antibody Product Offerings
Table 101. OriGene Recent Development
Table 102. Genscript Biotech Company Information
Table 103. Genscript Biotech Introduction and Business Overview
Table 104. Genscript Biotech Primary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 105. Genscript Biotech Primary Antibody Product Offerings
Table 106. Genscript Biotech Recent Development
Table 107. Proteintech Company Information
Table 108. Proteintech Introduction and Business Overview
Table 109. Proteintech Primary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 110. Proteintech Primary Antibody Product Offerings
Table 111. Proteintech Recent Development
Table 112. Roche Diagnostics Company Information
Table 113. Roche Diagnostics Introduction and Business Overview
Table 114. Roche Diagnostics Primary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 115. Roche Diagnostics Primary Antibody Product Offerings
Table 116. Roche Diagnostics Recent Development
Table 117. HyTest Company Information
Table 118. HyTest Introduction and Business Overview
Table 119. HyTest Primary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 120. HyTest Primary Antibody Product Offerings
Table 121. HyTest Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Primary Antibody Downstream Customers
Table 125. Primary Antibody Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Primary Antibody Product Picture
Figure 2. Global Primary Antibody Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Primary Antibody Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Primary Antibody Sales Volume (2019-2030) & (mg)
Figure 5. Global Primary Antibody Sales Price (2019-2030) & (USD/mg)
Figure 6. Primary Antibody Report Years Considered
Figure 7. Global Primary Antibody Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Primary Antibody Players Sales Volume Ranking (2023) & (mg)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Primary Antibody Revenue in 2023
Figure 10. Primary Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Monoclonal Antibodies Picture
Figure 12. Polyclonal Antibody Picture
Figure 13. Global Primary Antibody Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Primary Antibody Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Primary Antibody Sales Volume by Type (2019 VS 2023 VS 2030) & (mg)
Figure 16. Global Primary Antibody Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Primary Antibody Price by Type (2019-2030) & (USD/mg)
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Life Sciences
Figure 20. Product Picture of Laboratory
Figure 21. Global Primary Antibody Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Primary Antibody Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Primary Antibody Sales Volume by Application (2019 VS 2023 VS 2030) & (mg)
Figure 24. Global Primary Antibody Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Primary Antibody Price by Application (2019-2030) & (USD/mg)
Figure 26. North America Primary Antibody Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Primary Antibody Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Primary Antibody Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Primary Antibody Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Primary Antibody Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Primary Antibody Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Primary Antibody Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Primary Antibody Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Primary Antibody Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Primary Antibody Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Primary Antibody Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Primary Antibody Sales Volume (%), (2019-2030)
Figure 38. United States Primary Antibody Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Primary Antibody Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Primary Antibody Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Primary Antibody Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Primary Antibody Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Primary Antibody Sales Value by Application (%), 2023 VS 2030
Figure 44. China Primary Antibody Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Primary Antibody Sales Value by Type (%), 2023 VS 2030
Figure 46. China Primary Antibody Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Primary Antibody Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Primary Antibody Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Primary Antibody Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Primary Antibody Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Primary Antibody Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Primary Antibody Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Primary Antibody Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Primary Antibody Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Primary Antibody Sales Value by Application (%), 2023 VS 2030
Figure 56. India Primary Antibody Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Primary Antibody Sales Value by Type (%), 2023 VS 2030
Figure 58. India Primary Antibody Sales Value by Application (%), 2023 VS 2030
Figure 59. Primary Antibody Industrial Chain
Figure 60. Primary Antibody Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies